StocksFundsScreenerSectorsWatchlists
XRAY

XRAY - DENTSPLY SIRONA Inc Stock Price, Fair Value and News

30.89USD-0.41 (-1.31%)Market Closed

Market Summary

XRAY
USD30.89-0.41
Market Closed
-1.31%

XRAY Stock Price

View Fullscreen

XRAY RSI Chart

XRAY Valuation

Market Cap

6.4B

Price/Earnings (Trailing)

-47.62

Price/Sales (Trailing)

1.62

EV/EBITDA

207.04

Price/Free Cashflow

16.99

XRAY Price/Sales (Trailing)

XRAY Profitability

EBT Margin

-4.41%

Return on Equity

-4.08%

Return on Assets

-1.82%

Free Cashflow Yield

5.89%

XRAY Fundamentals

XRAY Revenue

Revenue (TTM)

4.0B

Rev. Growth (Yr)

2.95%

Rev. Growth (Qtr)

6.86%

XRAY Earnings

Earnings (TTM)

-134.5M

Earnings Growth (Yr)

563.33%

Earnings Growth (Qtr)

126.13%

Breaking Down XRAY Revenue

Last 7 days

-4.2%

Last 30 days

-5.9%

Last 90 days

-14.1%

Trailing 12 Months

-24.9%

How does XRAY drawdown profile look like?

XRAY Financial Health

Current Ratio

1.38

Debt/Equity

0.55

Debt/Cashflow

0.21

XRAY Investor Care

Dividend Yield

1.81%

Dividend/Share (TTM)

0.56

Buy Backs (1Y)

3.71%

Diluted EPS (TTM)

-0.62

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20233.9B3.9B3.9B4.0B
20224.2B4.1B4.0B3.9B
20213.5B4.0B4.2B4.2B
20204.0B3.5B3.4B3.3B
20194.0B3.9B4.0B4.0B
20184.0B4.1B4.0B4.0B
20173.9B3.8B3.9B4.0B
20162.8B3.1B3.4B3.7B
20152.8B2.8B2.7B2.7B
20142.9B3.0B3.0B2.9B
20132.9B2.9B3.0B3.0B
20122.7B2.8B2.9B2.9B
20112.2B2.3B2.4B2.5B
20102.2B2.2B2.2B2.2B
20092.1B2.1B2.1B2.2B
200802.1B2.1B2.2B
20070002.0B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of DENTSPLY SIRONA Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 12, 2024
johnson robert anthony
acquired
-
-
354
svp, chief supply chain office
Apr 12, 2024
lucier gregory t
acquired
-
-
26.426
-
Apr 12, 2024
frank andreas g
acquired
-
-
503
exec vp/chief business officer
Apr 12, 2024
mazelsky jonathan jay
acquired
-
-
26.426
-
Apr 12, 2024
campion simon d
acquired
-
-
1,088
president, ceo & member of bod
Apr 12, 2024
brandt eric
acquired
-
-
72.546
-
Apr 12, 2024
rosenzweig richard c
acquired
-
-
215
svp, corp dev, gc & secretary
Apr 12, 2024
coleman glenn
acquired
-
-
302
executive vp & cfo
Apr 12, 2024
wagner richard m
acquired
-
-
41.653
vp, chief accounting officer
Apr 12, 2024
holden betsy d
acquired
-
-
129
-

1–10 of 50

Which funds bought or sold XRAY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 12, 2024
FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC
reduced
-17.14
-137,000
468,000
0.05%
Apr 12, 2024
HARBOR INVESTMENT ADVISORY, LLC
unchanged
-
-151
2,091
-%
Apr 12, 2024
NORTHWEST INVESTMENT COUNSELORS, LLC
reduced
-0.48
-36,842
475,644
0.12%
Apr 12, 2024
FIRST FINANCIAL CORP /IN/
new
-
3,583
3,583
-%
Apr 12, 2024
DNB Asset Management AS
sold off
-100
-720,270
-
-%
Apr 12, 2024
AdvisorNet Financial, Inc
sold off
-100
-1,495
-
-%
Apr 12, 2024
BALDWIN BROTHERS LLC/MA
unchanged
-
-1,524
21,076
-%
Apr 11, 2024
SALEM INVESTMENT COUNSELORS INC
unchanged
-
-28,560
400,200
0.01%
Apr 11, 2024
Bangor Savings Bank
unchanged
-
-619
8,563
-%
Apr 10, 2024
PARK AVENUE SECURITIES LLC
reduced
-1.66
-24,000
263,000
-%

1–10 of 50

Are Funds Buying or Selling XRAY?

Are funds buying XRAY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own XRAY
No. of Funds

Unveiling DENTSPLY SIRONA Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.89%
25,187,041
SC 13G/A
Feb 12, 2024
artisan partners limited partnership
6.1%
12,944,034
SC 13G/A
Feb 05, 2024
nuance investments, llc
5.48%
11,603,889
SC 13G/A
Jan 29, 2024
blackrock inc.
6.2%
13,136,945
SC 13G/A
Feb 13, 2023
generation investment management llp
2.21%
4,747,746
SC 13G/A
Feb 10, 2023
artisan partners limited partnership
6.3%
13,582,284
SC 13G/A
Feb 09, 2023
vanguard group inc
11.69%
25,121,756
SC 13G/A
Feb 08, 2023
nuance investments, llc
5.88%
12,642,319
SC 13G
Feb 03, 2023
blackrock inc.
7.9%
16,978,584
SC 13G/A
Mar 09, 2022
blackrock inc.
10.9%
23,745,567
SC 13G/A

Recent SEC filings of DENTSPLY SIRONA Inc

View All Filings
Date Filed Form Type Document
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading
Apr 15, 2024
4
Insider Trading

Peers (Alternatives to DENTSPLY SIRONA Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
188.9B
40.1B
-5.73% 4.72%
33.01
4.71
-8.12% -17.45%
67.8B
19.5B
-0.88% -8.17%
53.97
3.48
4.02% -22.04%
22.9B
3.9B
-3.10% -11.00%
51.41
5.92
3.42% 23.09%
20.3B
14.8B
-3.77% -6.99%
7.66
1.37
2.12% 209.17%
MID-CAP
9.1B
3.5B
-1.99% 15.94%
32.07
2.62
4.97% 18.89%
9.1B
12.3B
-5.16% -14.19%
21.85
0.74
-2.44% -22.68%
8.8B
2.7B
-9.88% -37.29%
-13.77
3.29
-4.68% 82.43%
6.4B
4.0B
-5.94% -24.93%
-47.62
1.62
1.10% 85.84%
3.4B
366.4M
-0.71% 17.46%
-565.84
9.37
33.86% 89.83%
2.3B
6.6B
-6.94% -4.63%
11.73
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-3.79% -17.24%
-1.94
0.41
7.73% -1066.14%
376.4M
166.7M
-0.35% -8.55%
-4.55
2.26
6.67% -456.34%
253.5M
324.0M
17.88% -30.36%
-1.32
0.78
-3.19% -337.41%
47.8M
52.3M
-22.91% -54.00%
-2.55
0.91
17.61% 19.28%
3.8M
3.7M
-16.18% 262.50%
-0.31
1.01
5.77% 8.23%

DENTSPLY SIRONA Inc News

Latest updates
Defense World17 hours ago
Yahoo Finance02 Apr 202407:00 am
InvestorsObserver27 Mar 202407:00 am

DENTSPLY SIRONA Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue6.9%1,0129471,0289789839471,0239691,1031,0401,0621,0261,0768834998811,1129621,0099461,060
Gross Profit5.5%522495550519517508581521604569595579567432182475611514541500525
  S&GA Expenses9.9%409372416416402401410376377395393386373313259357325399431432433
  R&D Expenses-6.5%43.0046.0049.0046.0043.0041.0045.0045.0049.0039.0043.0040.0038.0029.0020.0036.00-----
EBITDA Margin369.4%0.01*0.00*-0.26*-0.25*-0.22*-0.18*0.15*0.16*0.17*0.17*0.16*0.12*0.04*--------
Interest Expenses27.8%23.0018.0021.0019.0024.0014.0015.0012.0018.0014.0015.0014.0014.0014.0011.007.007.007.008.008.009.00
Income Taxes-193.7%-15.0016.00-39.00-5.0023.00-16418.0018.0037.0029.0035.0033.0024.009.00-22.0012.0035.0022.0011.0015.0076.00
Earnings Before Taxes122.8%57.00-25046.00-28.008.00-1,24191.0087.0015611313114512957.00-114-12213010748.0054.0078.00
EBT Margin22.4%-0.04*-0.06*-0.31*-0.30*-0.27*-0.22*0.11*0.12*0.13*0.12*0.11*0.06*-0.01*--------
Net Income126.1%70.00-26685.00-23.00-15.00-1,07773.0069.0011984.0096.0011210547.00-91.00-13410285.0036.0039.002.00
Net Income Margin39.0%-0.03*-0.06*-0.26*-0.27*-0.24*-0.20*0.08*0.09*0.10*0.09*0.09*0.05*-0.02*--------
Free Cashflow19.4%160134104-58.25105109173-187--27.00242176144-40.75269----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets2.3%7,3707,2017,6507,6737,6437,5228,9489,1729,2399,2899,3789,1379,3508,8968,6048,0588,6038,3678,5758,6058,687
  Current Assets3.1%1,9731,9131,9201,9431,8931,9391,8851,8971,8521,8051,7851,6961,7982,5802,3631,8052,0001,8111,8281,7961,888
    Cash Equivalents8.1%3343092953183654183623743392813323184381,2721,109236405226250225310
  Inventory-4.1%6246516576596275925815535155485391.00476489549591562605608618599
  Net PPE-100.0%-753772770761714744771773771769758791772772777802783820854871
  Goodwill2.7%2,4382,3742,7032,7012,6882,5843,8583,9443,9764,0004,0333,9523,9863,2833,2273,1923,3973,3563,4133,3993,431
Liabilities6.4%4,0763,8303,9484,0353,8313,9084,1104,3084,2424,2264,3014,2074,4154,1343,9593,3683,5083,3083,3923,4953,554
  Current Liabilities17.0%1,4251,2181,2711,3741,1701,2961,2411,3721,2611,1991,2511,2121,3721,1787638929958698818711,013
  Long Term Debt-0.4%1,7961,8031,8411,8421,8261,7371,8071,8721,9131,9251,9461,9231,9781,9302,1831,4211,4331,4041,4411,5451,565
    LT Debt, Non Current-0.4%1,7961,8031,8411,8421,8261,7371,8071,8721,9131,9251,9461,9231,9781,9302,1831,4211,4331,4041,4411,5451,565
Shareholder's Equity-2.4%3,2933,3753,7023,6383,8113,6144,8384,8644,9975,0635,0344,8904,9354,7204,6084,6495,0485,0595,1835,1105,083
  Retained Earnings22.8%2051674634074564981,6021,5561,5141,4191,4021,3281,1981,1561,1251,2421,4041,3241,2621,2451,226
  Additional Paid-In Capital0.0%6,6436,6456,6486,6046,6296,6196,6176,5736,6066,6596,6386,6186,6046,5926,5776,5546,5876,5676,5516,5206,522
Shares Outstanding-2.2%207212212213215216216217217219219219219--------
Minority Interest125.0%1.00-4.00-4.00-3.001.001.001.001.001.003.003.003.003.002.002.003.002.002.002.002.0012.00
Float---8,463---7,665---13,791---9,606---13,062--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations19.4%160134104-21.0014210917393.00----264221174-10.0030615914529.00202
  Share Based Compensation550.0%13.002.0014.0017.0012.0014.0022.0011.00-6.0022.0019.0013.0011.0017.009.0010.0016.0015.0025.009.006.00
Cashflow From Investing-900.0%-20.00-2.00-30.00-37.00-29.00-26.00-40.00-43.00-----1,101-25.0036.00-16.00-29.30-15.20-11.80-12.70-48.00
Cashflow From Financing-17.4%-128-109-87.0017.00-161-6.00-152-10.00----53.00-15.00-37.00658-130-101-160-110-99.20-78.80
  Dividend Payments3.4%30.0029.0030.0027.0026.0027.0027.0024.0024.0024.0022.0022.0022.0022.0022.0022.0022.0020.0020.0020.0020.00
  Buy Backs-150--150---150110--90.00---14010010060.00--0.20

XRAY Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 3,965$ 3,922$ 4,231
Cost of products sold1,8791,7951,884
Gross profit2,0862,1272,347
Selling, general, and administrative expenses1,6131,5891,551
Research and development expenses184174171
Goodwill and intangible asset impairments3071,2870
Restructuring and other costs671417
Operating (loss) income(85)(937)608
Other income and expenses:   
Interest expense, net816561
Other expense (income), net9532
(Loss) income before income taxes(175)(1,055)545
(Benefit) provision for income taxes(43)(105)134
Net (loss) income(132)(950)411
Less: Net income (loss) attributable to noncontrolling interests000
Net (loss) income attributable to Dentsply Sirona$ (132)$ (950)$ 411
Net (loss) income per common share attributable to Dentsply Sirona:   
Basic (in dollars per share)$ (0.62)$ (4.41)$ 1.88
Diluted (in dollars per share)$ (0.62)$ (4.41)$ 1.87
Weighted average common shares outstanding:   
Basic (in shares)212.0215.5218.4
Diluted (in shares)212.0215.5220.2

XRAY Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 334$ 365
Accounts and notes receivable-trade, net695632
Inventories, net624627
Prepaid expenses and other current assets320269
Total Current Assets1,9731,893
Property, plant and equipment, net800761
Operating lease right-of-use assets, net178200
Identifiable intangible assets, net1,7051,903
Goodwill, net2,4382,688
Other noncurrent assets276198
Total Assets7,3707,643
Current Liabilities:  
Accounts payable305279
Accrued liabilities749727
Income taxes payable4946
Notes payable and current portion of long-term debt322118
Total Current Liabilities1,4251,170
Long-term debt1,7961,826
Operating lease liabilities125149
Deferred income taxes228287
Other noncurrent liabilities502399
Total Liabilities4,0763,831
Commitments and contingencies (Note 21)
Equity:  
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued00
Common stock, $0.01 par value; 400.0 million shares authorized at December 31, 2023 and 2022 264.5 million shares issued at December 31, 2023 and 2022 215.3 million and 215.3 million shares outstanding at December 31, 2023 and 2022, respectively33
Capital in excess of par value6,6436,629
Retained earnings205456
Accumulated other comprehensive loss(636)(628)
Treasury stock, at cost, 57.3 million and 49.3 million shares at December 31, 2023 and 2022, respectively(2,922)(2,649)
Total Dentsply Sirona Equity3,2933,811
Noncontrolling interests11
Total Equity3,2943,812
Total Liabilities and Equity$ 7,370$ 7,643
XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
 CEO
 WEBSITEdentsplysirona.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES15000

DENTSPLY SIRONA Inc Frequently Asked Questions


What is the ticker symbol for DENTSPLY SIRONA Inc? What does XRAY stand for in stocks?

XRAY is the stock ticker symbol of DENTSPLY SIRONA Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DENTSPLY SIRONA Inc (XRAY)?

As of Mon Apr 15 2024, market cap of DENTSPLY SIRONA Inc is 6.41 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XRAY stock?

You can check XRAY's fair value in chart for subscribers.

What is the fair value of XRAY stock?

You can check XRAY's fair value in chart for subscribers. The fair value of DENTSPLY SIRONA Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DENTSPLY SIRONA Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for XRAY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DENTSPLY SIRONA Inc a good stock to buy?

The fair value guage provides a quick view whether XRAY is over valued or under valued. Whether DENTSPLY SIRONA Inc is cheap or expensive depends on the assumptions which impact DENTSPLY SIRONA Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XRAY.

What is DENTSPLY SIRONA Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, XRAY's PE ratio (Price to Earnings) is -47.62 and Price to Sales (PS) ratio is 1.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XRAY PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on DENTSPLY SIRONA Inc's stock?

In the past 10 years, DENTSPLY SIRONA Inc has provided -0.032 (multiply by 100 for percentage) rate of return.